1.43
Compugen Ltd Borsa (CGEN) Ultime notizie
Compugen Ltd. stock prediction for this weekJuly 2025 Volume & Verified High Yield Trade Plans - Newser
Pattern recognition hints at Compugen Ltd. upsidePortfolio Risk Summary & Low Risk Entry Point Tips - Newser
Should you wait for a breakout in Compugen Ltd.July 2025 Closing Moves & Target Return Focused Stock Picks - Newser
What data driven models say about Compugen Ltd.’s future2025 Key Lessons & Weekly Watchlist for Hot Stocks - Newser
Real time scanner hits for Compugen Ltd. explainedDip Buying & Free Fast Gain Swing Trade Alerts - Newser
Applying chart zones and confluence areas to Compugen Ltd.Quarterly Market Summary & Reliable Breakout Forecasts - Newser
How to read the order book for Compugen Ltd.2025 Market Outlook & Smart Money Movement Tracker - Newser
What earnings revisions data tells us about Compugen Ltd.2025 Earnings Surprises & Real-Time Volume Trigger Notifications - Newser
Can Compugen Ltd. hit a new high this monthWeekly Trading Summary & Stock Portfolio Risk Management - Newser
Real time pattern detection on Compugen Ltd. stockJuly 2025 Technicals & Daily Stock Momentum Reports - Newser
Compugen Ltd. Chart Enters High Volatility ZoneCEO Change & Daily Technical Stock Forecast Reports - thegnnews.com
Historical volatility pattern of Compugen Ltd. visualizedPortfolio Growth Summary & Real-Time Market Trend Scan - Newser
Compugen Ltd. stock retracement – recovery analysis [July 2025 EndofMonth]Free Reliable Trade Execution Plans - Newser
Is Compugen Ltd. showing insider buyingLow Drawdown High Profit Portfolio - newsyoung.net
Can Compugen Ltd. recover in the next quarterReal-Time AI Sentiment and Price Forecast - Newser
Leerink Partnrs Predicts Increased Earnings for Compugen - Defense World
Is Compugen Ltd. forming a reversal patternStrategy Chart for Real-Time Trade Flow - Newser
Intrinsic Value of Compugen Ltd. Stock: Is It Undervalued or OvervaluedIn-Depth Stock Trading Volume Analysis - Newser
Compugen signals leadership transition and advances COM701 ovarian cancer trial with interim data targeted for 2026 - MSN
Need To Know: Analysts Just Made A Substantial Cut To Their Compugen Ltd. (NASDAQ:CGEN) Estimates - Yahoo Finance
Using portfolio simulators with Compugen Ltd. includedBuy Point Strategy with Profit Protection - Newser
How Compugen Ltd. stock performs during market volatilityPredictive Short-Term Market Reversal Alerts - Newser
Compugen (NASDAQ:CGEN) Downgraded by Wall Street Zen to Sell - Defense World
Using Bollinger Bands to evaluate Compugen Ltd.Free Capital Protection Trading Strategies - Newser
Using data tools to time your Compugen Ltd. exitForecast Model for Intraday Buy Signals - Newser
Understanding Compugen Ltd.’s price movementFree Weekly Hot Picks With Buy Confidence - Newser
How Efficient Is Compugen Ltd. at Controlling Operating CostsMarket Timing Strategy with Technical Filters - Newser
Compugen Reports Q2 2025 Earnings with Strategic Progress Amid Financial Challenges - AInvest
Compugen Reports Q2 Earnings: Revenue Down, Net Loss Up, and Ovarian Cancer Competition Rises Amid Strong Partnerships and Cash Reserves - AInvest
Compugen (CGEN) Gets a Buy from Leerink Partners - The Globe and Mail
Compugen Ltd. (NASDAQ:CGEN) Q2 2025 Earnings Call Transcript - Insider Monkey
Compugen's COM701 Shifts Focus to Targeting PSOC Patients, With Multiple Catalysts Ahead - AInvest
Compugen: Potential Best-In-Class Anti-PVRIG COM701 Shifts To Targeting PSOC Patients - Seeking Alpha
Will Compugen Ltd. Stock Benefit from AI and Green Energy TrendsRSI and MACD Signal Summary with Trends - Newser
Compugen Ltd. stock momentum explainedFree ROI Boosting Trade Opportunity Calendar - Newser
Compugen’s COM701 Trial: A Potential Game-Changer in Ovarian Cancer Treatment? - TipRanks
Compugen price target raised to $13 from $10 at Leerink - TipRanks
Compugen Reports Q2 2025 Results and Advances in Immuno-Oncology Trials - The Globe and Mail
Compugen stock price target raised to $13 from $10 at Leerink Partners - Investing.com Australia
Is Compugen Ltd. stock entering bullish territoryReliable Setup Screener with Low Risk - Newser
Compugen Reports Q2 2025 Results and Strategic Progress - TipRanks
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):